As the ED group #1 showed a distinct overall clinic-pathologic profile, with NSB location, absence of NHERF1 microlumens, and lack of overall recurrence, an interpretation of metaplastic meningioma, WHO grade I, appears to correspond more accurately to the biology of these tumors. This evidence concerns the gene NHERF1 and meningioma.